Proactive Investors - Run By Investors For Investors

LexaGene Holdings completes development of Antibiotic Resistance Panel

LexaGene Holdings (CVE:LXG-OTCQB:LXXGF) Co-Founder and CEO Dr Jack Regan joined Steve Darling from the Toronto studio of Proactive Investors to discuss their announcement dealing with antibiotic resistance.

Regan tells Proactive why this is needed and which industries they will be the only player in the market dealing with this.

 
View full LXG profile View Profile

Lexagene Holdings Inc Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use